{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:35:21Z","timestamp":1792157721098,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pathol.2023.10.010","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T07:45:31Z","timestamp":1701416731000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-4586","authenticated-orcid":false,"given":"Jan","family":"Hrudka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-2484","authenticated-orcid":false,"given":"Jan","family":"Hojn\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Prouzov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kendall B\u00e1rt\u016f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"\u010capka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Zavillov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-6343","authenticated-orcid":false,"given":"Radoslav","family":"Mat\u011bj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-5837","authenticated-orcid":false,"given":"Petr","family":"Waldauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2023.10.010_bib1","series-title":"Urologic Cancers","first-page":"11","article-title":"The epidemiology of penile cancer","author":"Giona","year":"2022"},{"key":"10.1016\/j.pathol.2023.10.010_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pathol.2023.10.010_bib3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ejca.2012.10.029","article-title":"EUNICE survival working group. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990","volume":"49","author":"Verhoeven","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pathol.2023.10.010_bib4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/ijc.31194","article-title":"Trends in incidence, mortality and survival of penile squamous cell carcinoma in Norway 1956-2015","volume":"142","author":"Hansen","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.pathol.2023.10.010_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2023.10.010_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.pathol.2023.03.010","article-title":"Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases","volume":"55","author":"Hrudka","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2023.10.010_bib7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3889\/oamjms.2019.219","article-title":"P53 and survival rate in penile cancer","volume":"7","author":"Prapiska","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.pathol.2023.10.010_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","article-title":"Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis","volume":"65","author":"Gunia","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2023.10.010_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00345-008-0275-y","article-title":"Molecular prognostic factors in penile cancer","volume":"27","author":"Muneer","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.pathol.2023.10.010_bib10","first-page":"81","article-title":"p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"168","author":"Lopes","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2023.10.010_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","article-title":"Clinical significance of p53 and p16(ink4a) status in a contemporary North American penile carcinoma cohort","volume":"14","author":"Zargar-Shoshtari","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.pathol.2023.10.010_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.clgc.2021.07.001","article-title":"p53 and p16ink4a as predictive and prognostic biomarkers for nodal metastasis and survival in a contemporary cohort of penile squamous cell carcinoma","volume":"19","author":"Mohanty","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.pathol.2023.10.010_bib13","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"key":"10.1016\/j.pathol.2023.10.010_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/his.13429","article-title":"Members of the ISUP penile tumor panel. The World Health Organization 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations","volume":"72","author":"Cubilla","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.10.010_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.10.010_bib16","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2023.10.010_bib17","series-title":"WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours","first-page":"372","article-title":"Tumours of the penis and scrotum","author":"Amin","year":"2022"},{"key":"10.1016\/j.pathol.2023.10.010_bib18","series-title":"R: A Language and Environment for Statistical Computing","year":"2019"},{"key":"10.1016\/j.pathol.2023.10.010_bib19","series-title":"A\u00a0package for survival analysis in R. Version 3.1\u20137","author":"Therneau","year":"2015"},{"key":"10.1016\/j.pathol.2023.10.010_bib20","doi-asserted-by":"crossref","first-page":"FSO195","DOI":"10.4155\/fsoa-2017-0031","article-title":"Immunotherapy for penile cancer","volume":"3","author":"Buonerba","year":"2017","journal-title":"Future Sci OA"},{"key":"10.1016\/j.pathol.2023.10.010_bib21","doi-asserted-by":"crossref","first-page":"E383","DOI":"10.1111\/j.1464-410X.2012.11735.x","article-title":"Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis","volume":"112","author":"May","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2023.10.010_bib22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","article-title":"Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis","volume":"159","author":"Rubin","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2023.10.010_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1827.2008.02259.x","article-title":"Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men","volume":"58","author":"Yanagawa","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.pathol.2023.10.010_bib24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/modpathol.2017.26","article-title":"HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common","volume":"30","author":"Kashofer","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.10.010_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152881","article-title":"High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features","volume":"216","author":"Liu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.pathol.2023.10.010_bib26","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.3390\/cancers13184659","article-title":"PD-L1 expression is significantly associated with tumor mutation burden and microsatellite instability score","volume":"13","author":"Cho","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2023.10.010_bib27","article-title":"Progress and prospect of immunotherapy for triple-negative breast cancer","volume":"12","author":"Luo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2023.10.010_bib28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamaoncol.2022.1981","article-title":"Association of high tumor mutation burden in non-small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels","volume":"8","author":"Ricciuti","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.pathol.2023.10.010_bib29","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-20-4004","article-title":"Whole-exome sequencing in penile squamous cell carcinoma uncovers novel prognostic categorization and drug targets similar to head and neck squamous cell carcinoma","volume":"27","author":"Chahoud","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.10.010_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12094-021-02694-7","article-title":"The peri- and intratumoral immune cell infiltrate and PD-L1 status in invasive squamous cell carcinomas of the penis","volume":"24","author":"M\u00fcller","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.pathol.2023.10.010_bib31","first-page":"690","article-title":"Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status","volume":"197","author":"Ottenhof","year":"2017","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2023.10.010_bib32","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/j.clgc.2019.10.014","article-title":"PD-L1 and p16 expression in penile squamous cell carcinoma from an endemic region","volume":"18","author":"De Bacco","year":"2020","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.pathol.2023.10.010_bib33","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","article-title":"CSN1 somatic mutations in penile squamous cell carcinoma","volume":"76","author":"Feber","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2023.10.010_bib34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3389\/fimmu.2018.01253","article-title":"The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma","volume":"9","author":"Ottenhof","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2023.10.010_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2016.09.003","article-title":"Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort","volume":"59","author":"Cocks","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2023.10.010_bib36","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","article-title":"Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches","volume":"27","author":"Udager","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2023.10.010_bib37","article-title":"Tumor PD-L1 expression is correlated with increased TILs and poor prognosis in penile squamous cell carcinoma","volume":"6","author":"Deng","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pathol.2023.10.010_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.euo.2018.07.010","article-title":"PD-l1 expression in men with penile cancer and its association with clinical outcomes","volume":"2","author":"Davidsson","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.pathol.2023.10.010_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1013806","article-title":"PD-L1 is associated with the prognosis of penile cancer: a systematic review and meta-analysis","volume":"12","author":"Lu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.pathol.2023.10.010_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00292-018-0507-x","article-title":"Der pr\u00e4diktive wert der PD-L1-diagnostik","volume":"39","author":"Schildhaus","year":"2018","journal-title":"Pathologe"},{"key":"10.1016\/j.pathol.2023.10.010_bib41","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.21873\/anticanres.15628","article-title":"PD-L1 Expression and survival rates using TPS and CPS for nivolumab-treated head-and-neck cancer","volume":"42","author":"Ito","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pathol.2023.10.010_bib42","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00428-022-03271-1","article-title":"Tumor-associated immune cell infiltrate density in penile squamous cell carcinomas","volume":"480","author":"Hladek","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2023.10.010_bib43","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s13277-014-2864-2","article-title":"Pathologic and immunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: fox-P3 expression is an independent predictor of recurrence","volume":"36","author":"Vassallo","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.pathol.2023.10.010_bib44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00428-014-1713-4","article-title":"Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes","volume":"466","author":"Lohneis","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2023.10.010_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.4287","article-title":"Towards the introduction of the 'Immunoscore' in the classification of malignant tumours","volume":"232","author":"Galon","year":"2014","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2023.10.010_bib46","article-title":"Immunotherapy in penile squamous cell carcinoma: present or future? Multi-target analysis of programmed cell death ligand 1 expression and microsatellite instability","volume":"9","author":"Montella","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.pathol.2023.10.010_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000495251","article-title":"No evidence of microsatellite instability and loss of mismatch-repair-protein expression in squamous cell carcinoma of the penis","volume":"86","author":"Stoehr","year":"2019","journal-title":"Pathobiology"},{"key":"10.1016\/j.pathol.2023.10.010_bib48","first-page":"541","article-title":"Comparative genomic profiling of refractory and metastatic penile and nonpenile cutaneous squamous cell carcinoma: implications for selection of systemic therapy","volume":"201","author":"Jacob","year":"2019","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2023.10.010_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523003070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523003070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T03:21:31Z","timestamp":1710472891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302523003070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0031302523003070"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2023.10.010","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2023.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}